(Q40720181)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11243397%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Second malignancy after treatment of childhood acute myeloid leukemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11243397%20AND%20SRC:MED&resulttype=core&format=json

childhood acute myeloid leukemia

5 November 2019

main subject

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11243397%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

W Leung

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11243397%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

R C Ribeiro

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11243397%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

M Hudson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11243397%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

X Tong

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11243397%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

D K Srivastava

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11243397%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

J T Sandlund

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11243397%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

B I Razzouk

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11243397%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

W E Evans

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11243397%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

C H Pui

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11243397%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 January 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11243397%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11243397%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11243397%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11243397%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

41-45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11243397%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401948

7 January 2021

Late effects of treatment in survivors of childhood acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401948

7 January 2021

Splenectomy and chemotherapy in acute myelocytic leukemia of childhood

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401948

7 January 2021

Preventive central nervous system irradiation in children with acute nonlymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401948

7 January 2021

Allogeneic bone marrow transplantation in a program of intensive sequential chemotherapy for children and young adults with acute nonlymphocytic leukemia in first remission

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401948

7 January 2021

Early intensification of chemotherapy for childhood acute nonlymphoblastic leukemia: improved remission induction with a five-drug regimen including etoposide.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401948

7 January 2021

Treatment of childhood acute myelogenous leukemia with an intensive regimen (AML-87) that individualizes etoposide and cytarabine dosages: short- and long-term effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401948

7 January 2021

Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401948

7 January 2021

Late effects in survivors of infant leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401948

7 January 2021

Effective reinduction therapy for childhood acute nonlymphoid leukemia using simultaneous continuous infusions of teniposide and amsacrine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401948

7 January 2021

Risk of second tumors in survivors of childhood cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401948

7 January 2021

Incidence of second malignant neoplasms in children: results of an international study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401948

7 January 2021

Second malignant neoplasms in children: an update from the Late Effects Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401948

7 January 2021

Risk of second cancer after cancer in childhood

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401948

7 January 2021

Long-term risk of second malignant neoplasm after a cancer in childhood

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401948

7 January 2021

Second malignancies in very-long-term survivors of childhood cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401948

7 January 2021

Second malignant neoplasms after cancer in childhood or adolescence. Nordic Society of Paediatric Haematology and Oncology Association of the Nordic Cancer Registries

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401948

7 January 2021

Second malignant neoplasms after a first cancer in childhood: temporal pattern of risk according to type of treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401948

7 January 2021

Incidence of second primary tumours among childhood cancer survivors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401948

7 January 2021

Late deaths and second primary malignancies among long-term survivors of childhood cancer: an Italian multicentre study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401948

7 January 2021

Second malignant tumors after elective end of therapy for a first cancer in childhood: a multicenter study in Italy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401948

7 January 2021

Second malignant tumors following treatment during childhood and adolescence for cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401948

7 January 2021

Second neoplasms after acute lymphoblastic leukemia in childhood.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401948

7 January 2021

Second malignant neoplasms in patients treated for childhood leukemia. A population-based cohort study from the Nordic countries. The Nordic Society of Pediatric Oncology and Hematology (NOPHO).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401948

7 January 2021

Second malignancies in patients treated for childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401948

7 January 2021

Second malignancy following treatment of acute lymphoblastic leukemia in children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401948

7 January 2021

High incidence of secondary brain tumours after radiotherapy and antimetabolites.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401948

7 January 2021

Secondary brain tumors in children treated for acute lymphoblastic leukemia at St Jude Children's Research Hospital

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401948

7 January 2021

Malignant parotid tumors in patients previously treated for childhood cancer: clinical and imaging findings in eight cases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401948

7 January 2021

Solid cancers after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401948

7 January 2021

Malignant neoplasms in long-term survivors of bone marrow transplantation. Late Effects Working Party of the European Cooperative Group for Blood and Marrow Transplantation and the European Late Effect Project Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401948

7 January 2021

New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401948

7 January 2021

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401948

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2401948

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11243397%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

5 November 2019

1053571165

0 references

1 reference